Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration

PURPOSE: Understanding the immunobiology of the 15% to 30% of patients with follicular lymphoma (FL) who experience progression of disease within 24 months (POD24) remains a priority. Solid tumors with low levels of intratumoral immune infiltration have inferior outcomes. It is unknown whether a sim...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobin, Joshua W.D., Keane, Colm, Gunawardana, Jay, Mollee, Peter, Birch, Simone, Hoang, Thanh, Lee, Justina, Li, Li, Huang, Li, Murigneux, Valentine, Fink, J. Lynn, Matigian, Nicholas, Vari, Frank, Francis, Santiyagu, Kridel, Robert, Weigert, Oliver, Haebe, Sarah, Jurinovic, Vindi, Klapper, Wolfram, Steidl, Christian, Sehn, Laurie H., Law, Soi-Cheng, Wykes, Michelle N., Gandhi, Maher K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881104/
https://www.ncbi.nlm.nih.gov/pubmed/31461379
http://dx.doi.org/10.1200/JCO.18.02365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881104/
https://www.ncbi.nlm.nih.gov/pubmed/31461379
http://dx.doi.org/10.1200/JCO.18.02365

Ejemplares similares